mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.5 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.5 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.5 |
mRNA |
CP724714 |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
Parthenolide |
GDSC1000 |
pan-cancer |
AAC |
0.033 |
0.5 |
mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
0.031 |
0.5 |
mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |